Home » Topics » Conferences

Conferences
RSS

Clinical response to PAF antagonist associated with adhesion molecule suppression

May 16, 1997

Insights on asthma research approaches

May 16, 1997

LAS-31025 demonstrates good safety and efficacy in mild to moderate asthma

May 16, 1997

Anti-CD4 MAb effective in chronic, severe asthma

May 16, 1997

Tiotropium safe and effective in COPD

May 16, 1997

Selectin inhibitor effective in animal model of early- and late-phase airways inflammation

May 16, 1997

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

May 16, 1997

ABT-080 effective in animal model of lung eosinophilia

May 16, 1997

In vitro characterization of novel CysLTD1 receptor antagonist

May 16, 1997

Endothelin receptor blockade for airways inflammation

May 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.